EICHOR
● Completed
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Condition: Cushing's Syndrome I · Cushing Disease Due to Increased ACTH Secretion · Cortisol Excess · Sponsor: Sparrow Pharmaceuticals
About this study
This is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor. Subjects will receive each of the following 2 treatments for 24 weeks: SPI-62 and matching placebo with the option of long-term extension.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| St. Joseph's Hospital and Medical Center - Barrow Neurological Institute (BNI) - Pituitary Center | Phoenix, Arizona, United States | — |
| Southwest General Healthcare Center | Fort Myers, Florida, United States | — |
| Mayo Clinic Cancer Center (MCCC) - Rochester | Rochester, Minnesota, United States | — |
| Washington University School of Medicine - Center for Advanced Medicine (CAM) | St Louis, Missouri, United States | — |
| Comprehensive and Interventional Pain Management Llp | Henderson, Nevada, United States | — |
| Memorial Sloan-Kettering Cancer Center | New York, New York, United States | — |
| Oregon Health & Science University (OHSU) - Northwest Pituitary Center | Portland, Oregon, United States | — |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | — |
| Medical University of Plovdiv | Plovdiv, Bulgaria | — |
| Clinical Center of Endocrinology and Gerontology, University Hospital of Endocrinology, Medical University Sofia (USHATE) | Sofia, Bulgaria | — |
| Medical University of Sofia | Sofia, Bulgaria | — |
| Carol Davila University of Medicine and Pharmacy | Bucharest, Romania | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05307328